Transgender peoples' perspectives of being diagnosed with gender-associated cancer
https://www.facingourrisk.org/XRAY/transgender-peoples-perspectives-of-gender-associated-cancer
Full article: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.32784
An ABC News article provides viewpoints and data that conveys the added stress experienced by transgender and gender-nonconforming people when they are diagnosed with gender-associated cancer (e.g., ovarian or prostate cancer) that does not match their gender identity. (posted 9/13/21)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- What’s the process for getting cancer screening?
- Which local clinics for cancer screening or treatment are more welcoming and understanding of transgender individuals?
- What healthcare professionals will be involved in my cancer care?
- Will cancer treatment adversely interact with the gender-affirming therapy that I’m currently using?
- Will cancer treatment affect any future gender-affirming care in my future?
- What is my risk of cancer?
Open Clinical Trials
The following studies are enrolling people from the LGBTQ+ community.
- PRIDE Study: The PRIDE Study is the first long-term national health study of LGBTQ+ people. The goal is to improve the long-term health and wellness of LGBTQ+ people.
-
NCT05845476: Sexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and Evaluation (SOGI). The overall goal of this proposal is to assess multi-level barriers associated with sexual orientation and gender identity (SOGI) data collection in the health record as well as implementation factors including feasibility, acceptability, and data completeness.
Visit our Featured Research Page and Research Search and Enroll Tool to find additional studies enrolling people with, or at high risk for cancer. Note: Most of these trials are geared towards cisgender people.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.